Gennao Bio, Inc. — Form D/A
Gennao Bio, Inc. of Pennington, NJ, a company, filed a Form D amendment with the SEC on 2021-12-28. The offering totals $55.0M, of which $32.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-12-28
- Form: D/A
- Accession: 0001567619-21-022547
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $55.0M
- Amount sold: $32.5M
- Remaining: $22.5M
- Investors: 7
- Date of first sale: 2021-05-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-400266
Issuer
- Name: Gennao Bio, Inc.
- CIK: 0001862102
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 311 Pennington Rocky Hill Road, Pennington, NJ, 08534
- Phone: 212-739-6400
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Chau Khuong | Director | San Francisco, CA |
| Bruce Turner | Director | Gladwyne, PA |
| Stephen Squinto | Director | Stamford, CT |
| Stephen Squinto | Executive Officer | Stamford, CT |
| Stephen Squinto | Promoter | Stamford, CT |
| Peter Thompson | Director | Chanhassen, MN |
| Bradley Campbell | Director | Tampa, FL |
| CRAIG GORDON | Director | NOVATO, CA |
| Gary Sender | Director | Bryan, TX |
| Julie Hambleton | Director | Pennington, NJ |
| Anuj Goswami | Executive Officer | Pennington, NJ |
| Claudine Prowse | Executive Officer | Pennington, NJ |
| Joe McIntosh | Executive Officer | Pennington, NJ |
| Dale Ludwig | Executive Officer | Pennington, NJ |
| Chris Duke | Executive Officer | Pennington, NJ |
Other filings by this issuer (2)
More